Care Choreographies and the Making of the Psychosocial in Genetic Counseling
- Conditions
- Genetic Counselor
- Registration Number
- NCT06280833
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Brief Summary
Background:
Genetic counselors play a new and evolving role in medical care. Recent advances in genetic testing are changing many health care treatments, and genetic counselors play a key role in teaching people how their genes may affect both health and treatments. Genetic counselors may also help guide people through complex talks about their treatment risks; their chances for recovery; and their social and emotional health and wellbeing. Researchers want to learn more about the role genetic counselors play in health care.
Objective:
To observe how genetic counselors at NIH manage the social and psychological aspects of patient care.
Eligibility:
Genetic counselors who work at NIH. People aged 18 years or older who are scheduled to meet with one of these counselors are also needed.
Design:
An investigator will sit in on the session between the counselor and the participant. The investigator will take notes. The session will not be recorded. The investigator will leave at any point if asked.
The investigator will focus on talk about social and psychological care. That person will also listen to talk about risk; diagnosis; odds of recovery; and hope, grief, and loss. That person will note strategies that help the participant manage their emotions and how they perceive their risks.
Counselors may later have a 1-hour interview with the investigator. They will answer questions about their experiences as a care provider at NIH.
Participants will have only 1 session with the investigator. Counselors may have 4 to 10 sessions with an investigator over 8 months.
- Detailed Description
Study Description:
This is an ethnographic study of genetic counseling practice at NIH. The project will involve two phases: direct observation and open-ended interviews. Phase I (direct observation) will involve the associate investigator, Sarah Roth, observing genetic counseling sessions and genetic counseling team meetings. She will take observational field notes on discussions of psychosocial care among counselors, as well as clinical communication around risk; diagnosis and prognosis; hope, grief, and loss; and counseling strategies that address the relationship between risk perception and emotion. For Phase I, we will recruit all participants from NIH teams.
For Phase II (open-ended interviews), we will ask approximately 20 selected participants from interdisciplinary clinical teams for interviews (i.e., genetic counselors from Phase I). The same investigator will conduct open-ended interviews with contacted NIH staff regarding the role of genetic counselors in the institutional landscape. Interviews will last approximately 60 minutes. They will be audio-recorded and then transcribed by a third-party contracting service which has been used in previous NIH studies.
Objectives:
The objectives of this study are to ethnographically describe the everyday care work of genetic counseling; explore genetic counselors descriptions and uses of psychosocial care modalities in protocols; and characterize the role of genetic counselors in broader systems of medical care.
Endpoints:
Data from direct observations and interviews will be synthesized into a qualitative codebook. Themes will include self-perception; discussions of psychosocial care, discussions of risk and emotion, and clinical communication around risk; diagnosis and prognosis; and hope, grief, and loss.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Care Ongoing Data from direct observations and interviews will be synthesized into a qualitative codebook. Themes will include self-perception; discussions of psychosocial care, discussions of risk and emotion, and clinical communication around risk; diagnosis and prognosis; and hope, grief, and loss.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Human Genome Research Institute (NHGRI)
🇺🇸Bethesda, Maryland, United States